Abstract
Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated with CDK4/6 Inhibitors?
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have